GlassScriptPhysician profile
William T Cook
NPI 1740234780
$3,029.96
in general payments reported to CMS, 2019-2025
35 companies · $87.86 in 2025
The $87.86 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $292 · 2021: $775 · 2022: $674 · 2023: $439 · 2024: $298 · 2025: $87.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $667.74 | 2019-2024 | Lo Loestrin Fe, Orilissa, Qulipta |
| Astellas Pharma US INC | $289.05 | 2019-2024 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $209.78 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $178.47 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $155.75 | 2021-2022 | |
| Daiichi Sankyo INC. | $135.01 | 2019-2022 | |
| Hologic Sales and Service, LLC | $120.16 | 2019-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Gynesonics, INC. | $108.68 | 2021 | |
| Scynexis, INC. | $104.50 | 2021-2022 | |
| Coopersurgical, INC. | $99.88 | 2019-2023 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Aspira Women'S Health INC | $96.66 | 2022 | |
| Exeltis, USA INC. | $80.49 | 2020-2021 | |
| Evofem Biosciences, INC. | $73.82 | 2020-2023 | Phexxi |
| Sumitomo Pharma America, INC. | $62.06 | 2025 | Myfembree |
| Organon LLC | $61.90 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $61.66 | 2019-2021 | |
| Allergan, INC. | $50.11 | 2019-2021 | |
| Boston Scientific Corporation | $49.01 | 2020-2022 | |
| Baxter Healthcare | $44.80 | 2024 | Perclot |
| Pfizer INC. | $44.74 | 2023 | |
| Convatec INC. | $41.50 | 2022-2023 | |
| Millicent US INC | $41.23 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $35.72 | 2019 | |
| Minerva Surgical, INC | $29.09 | 2024 | |
| Lupin INC. | $24.76 | 2019 | |
| Bausch Health US, LLC | $24.51 | 2021 | |
| Shield Therapeutics INC | $22.58 | 2022 | |
| Meditrina | $17.51 | 2024 | |
| Lsi Solutions INC | $15.51 | 2022 | |
| Avion Pharmaceuticals | $15.24 | 2022 | |
| Agile Therapeutics, INC. | $15.01 | 2024 | Twirla |
| Acessa Health INC. | $14.52 | 2021 | |
| Glaxosmithkline, LLC. | $14.46 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.24 | 2019 | |
| Medtronic, INC. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.